Cargando…

A Novel ARMC5 Germline Variant in Primary Macronodular Adrenal Hyperplasia Using Whole-Exome Sequencing

Background: Primary macronodular adrenocortical hyperplasia (PMAH) is a rare form of adrenal Cushing’s syndrome with incomplete penetrance which may be sporadic or autosomal dominant. The inactivation of the ARMC5 gene, a potential tumor suppressor gene, is one of the associated causes of PMAH. This...

Descripción completa

Detalles Bibliográficos
Autores principales: Eghbali, Maryam, Cheraghi, Sara, Samanian, Sara, Rad, Iman, Meghdadi, Jafar, Akbari, Hamideh, Honardoost, Maryam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9777150/
https://www.ncbi.nlm.nih.gov/pubmed/36553033
http://dx.doi.org/10.3390/diagnostics12123028
_version_ 1784856033158496256
author Eghbali, Maryam
Cheraghi, Sara
Samanian, Sara
Rad, Iman
Meghdadi, Jafar
Akbari, Hamideh
Honardoost, Maryam
author_facet Eghbali, Maryam
Cheraghi, Sara
Samanian, Sara
Rad, Iman
Meghdadi, Jafar
Akbari, Hamideh
Honardoost, Maryam
author_sort Eghbali, Maryam
collection PubMed
description Background: Primary macronodular adrenocortical hyperplasia (PMAH) is a rare form of adrenal Cushing’s syndrome with incomplete penetrance which may be sporadic or autosomal dominant. The inactivation of the ARMC5 gene, a potential tumor suppressor gene, is one of the associated causes of PMAH. This study aimed to identify the variant responsible for Iranian familial PMAH. Methods: The proband, a 44-year-old woman, was directed to whole-exome sequencing (WES) of the blood sample to discover a germline variant. In addition, the identified causative variant was confirmed and segregated in other and available unaffected family members. Results: The novel germline heterozygous missense variant, c.2105C>A in the ARMC5 gene, was found, and the same germline variant as the proband was confirmed in two affected sisters. This variant was detected in the brother of the proband with an asymptomatic condition and this considered because of incomplete penetrance and age-dependent appearance. The function of the ARMC5 protein would be damaged by the identified variant, according to in silico and computer analyses that followed. Conclusion: The new germline ARMC5 variation (c.2105C>A, (p. Ala702Glu)) was interpreted as a likely pathogenic variant based on ACMG and Sherloc standards. PMAH may be diagnosed early using genetic testing that shows inherited autosomal dominant mutations in the ARMC5 gene.
format Online
Article
Text
id pubmed-9777150
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-97771502022-12-23 A Novel ARMC5 Germline Variant in Primary Macronodular Adrenal Hyperplasia Using Whole-Exome Sequencing Eghbali, Maryam Cheraghi, Sara Samanian, Sara Rad, Iman Meghdadi, Jafar Akbari, Hamideh Honardoost, Maryam Diagnostics (Basel) Article Background: Primary macronodular adrenocortical hyperplasia (PMAH) is a rare form of adrenal Cushing’s syndrome with incomplete penetrance which may be sporadic or autosomal dominant. The inactivation of the ARMC5 gene, a potential tumor suppressor gene, is one of the associated causes of PMAH. This study aimed to identify the variant responsible for Iranian familial PMAH. Methods: The proband, a 44-year-old woman, was directed to whole-exome sequencing (WES) of the blood sample to discover a germline variant. In addition, the identified causative variant was confirmed and segregated in other and available unaffected family members. Results: The novel germline heterozygous missense variant, c.2105C>A in the ARMC5 gene, was found, and the same germline variant as the proband was confirmed in two affected sisters. This variant was detected in the brother of the proband with an asymptomatic condition and this considered because of incomplete penetrance and age-dependent appearance. The function of the ARMC5 protein would be damaged by the identified variant, according to in silico and computer analyses that followed. Conclusion: The new germline ARMC5 variation (c.2105C>A, (p. Ala702Glu)) was interpreted as a likely pathogenic variant based on ACMG and Sherloc standards. PMAH may be diagnosed early using genetic testing that shows inherited autosomal dominant mutations in the ARMC5 gene. MDPI 2022-12-02 /pmc/articles/PMC9777150/ /pubmed/36553033 http://dx.doi.org/10.3390/diagnostics12123028 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Eghbali, Maryam
Cheraghi, Sara
Samanian, Sara
Rad, Iman
Meghdadi, Jafar
Akbari, Hamideh
Honardoost, Maryam
A Novel ARMC5 Germline Variant in Primary Macronodular Adrenal Hyperplasia Using Whole-Exome Sequencing
title A Novel ARMC5 Germline Variant in Primary Macronodular Adrenal Hyperplasia Using Whole-Exome Sequencing
title_full A Novel ARMC5 Germline Variant in Primary Macronodular Adrenal Hyperplasia Using Whole-Exome Sequencing
title_fullStr A Novel ARMC5 Germline Variant in Primary Macronodular Adrenal Hyperplasia Using Whole-Exome Sequencing
title_full_unstemmed A Novel ARMC5 Germline Variant in Primary Macronodular Adrenal Hyperplasia Using Whole-Exome Sequencing
title_short A Novel ARMC5 Germline Variant in Primary Macronodular Adrenal Hyperplasia Using Whole-Exome Sequencing
title_sort novel armc5 germline variant in primary macronodular adrenal hyperplasia using whole-exome sequencing
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9777150/
https://www.ncbi.nlm.nih.gov/pubmed/36553033
http://dx.doi.org/10.3390/diagnostics12123028
work_keys_str_mv AT eghbalimaryam anovelarmc5germlinevariantinprimarymacronodularadrenalhyperplasiausingwholeexomesequencing
AT cheraghisara anovelarmc5germlinevariantinprimarymacronodularadrenalhyperplasiausingwholeexomesequencing
AT samaniansara anovelarmc5germlinevariantinprimarymacronodularadrenalhyperplasiausingwholeexomesequencing
AT radiman anovelarmc5germlinevariantinprimarymacronodularadrenalhyperplasiausingwholeexomesequencing
AT meghdadijafar anovelarmc5germlinevariantinprimarymacronodularadrenalhyperplasiausingwholeexomesequencing
AT akbarihamideh anovelarmc5germlinevariantinprimarymacronodularadrenalhyperplasiausingwholeexomesequencing
AT honardoostmaryam anovelarmc5germlinevariantinprimarymacronodularadrenalhyperplasiausingwholeexomesequencing
AT eghbalimaryam novelarmc5germlinevariantinprimarymacronodularadrenalhyperplasiausingwholeexomesequencing
AT cheraghisara novelarmc5germlinevariantinprimarymacronodularadrenalhyperplasiausingwholeexomesequencing
AT samaniansara novelarmc5germlinevariantinprimarymacronodularadrenalhyperplasiausingwholeexomesequencing
AT radiman novelarmc5germlinevariantinprimarymacronodularadrenalhyperplasiausingwholeexomesequencing
AT meghdadijafar novelarmc5germlinevariantinprimarymacronodularadrenalhyperplasiausingwholeexomesequencing
AT akbarihamideh novelarmc5germlinevariantinprimarymacronodularadrenalhyperplasiausingwholeexomesequencing
AT honardoostmaryam novelarmc5germlinevariantinprimarymacronodularadrenalhyperplasiausingwholeexomesequencing